Arkolith/Insider Trading/HUMA/Form 4

Sebelius Kathleen

DirectorHumacyte, Inc. (HUMA) · full profile →Form 4 · filed Sep 11, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$28K
Net Open-Market Flow
-$28K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 10, 2024Sell(S)2K$5.39$8K41K
Sep 10, 2024Option exercise(M)2K$3.35$8K43K
Sep 10, 2024Option exercise(M)5K$4.34$20K44K
Sep 10, 2024Sell(S)4K$5.41$20K40K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 10, 2024Option exercise(M)5K—$04K
Sep 10, 2024Option exercise(M)2K—$06K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001818382-24-000186) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Humacyte, Inc.

Build

Ask your agent about HUMA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001818382-24-000186"
Ask your agent
Use Arkolith to summarize insider buying and selling at Humacyte, Inc.
over the last 90 days and cite the filings.